Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Dr. Dennis Slamon talks about targeted therapies at the Jonsson Comprehensive Cancer Center

POSTED: Apr. 29, 2008 Share/Bookmark

Dr. Dennis Slamon, JCCC Director of Clinical/Translational Research, identifies different genes and pathways to design therapies specifically to what drives cancer. The result is more effective and less toxic therapies such as Herceptin.

Last updated: 1/25/2010 11:16:19 AM